酒さ治療市場レポート：2030年までの動向、予測、競合分析

酒さの治療動向と予測

世界の酒さ治療市場は、2024年から2030年までのCAGR 7.8%で、2030年までに推定31億6,000万米ドルに達すると予想されています。この市場の主な促進要因は、酒さの発症率と有病率の上昇と併用療法、併用製品の傾向の拡大、および高齢者の数の増加です。世界の酒さ治療市場の将来は、抗生物質、アルファアゴニスト、レチノイド、コルチコステロイド、免疫抑制剤、降圧剤市場での機会があり、有望に見えます。

酒さ治療市場に関する洞察

Lucintelは、トピックスは予測期間中に最高の成長を遂げると予想しています。

北米は、消費者の知識の拡大、新薬の開発、正確な診断のための技術開発により、予測期間中に最も高い成長を遂げると予想されています。

よくある質問

Q.1酒さ治療の市場規模はどれくらいですか：

A1.世界の酒さ治療市場は、2030年までに推定31億6,000万米ドルに達すると予想されています。

Q.2酒さ治療市場の成長予測は何ですか：

A2.世界の酒さ治療市場は、2024年から2030年にかけて7.8%のCAGRで成長すると予想されています。

Q.3酒さ治療市場の成長に影響を与える主な要因は何ですか：

A3.この市場の主な促進要因は、酒さの発生率と併用療法の有病率の上昇、併用製品の傾向の増大、および高齢者の数の増加です。

Q4.市場の主要セグメントは：

A4.酒さ治療市場の将来は、抗生物質、アルファアゴニスト、レチノイド、コルチコステロイド、免疫抑制剤、降圧剤市場での機会があり、有望に見えます。

Q5.市場の主要企業は：

A5.主な酒さ治療会社は以下の通りです。

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• Anaptysbio

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、トピックスは予測期間中に最高の成長を遂げると予想しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、消費者の知識の拡大、新薬の開発、正確な診断のための技術開発により、予測期間中に最も高い成長を遂げると予想されています。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の酒さ治療市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の酒さ治療市場の動向（2018～2023年）と予測（2024～2030年）
• 薬剤クラス別の世界の酒さ治療市場
  • 抗生物質
  • アルファアゴニスト
  • レチノイド
  • コルチコステロイド
  • 免疫抑制剤
  • 降圧剤
  • その他
• 投与方法別の世界の酒さ治療市場
  • 外用
  • 経口

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の酒さ治療市場
• 北米の酒さ治療市場
• 欧州の酒さ治療市場
• アジア太平洋の酒さ治療市場
• その他地域の酒さ治療市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 薬剤クラス別の世界の酒さ治療市場の成長機会
  • 投与方法別の世界の酒さ治療市場の成長機会
  • 地域別の世界の酒さ治療市場の成長機会
• 世界の酒さ治療市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の酒さ治療市場の能力拡大
  • 世界の酒さ治療市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• AnaptysBio

Rosacea Treatment Trends and Forecast

The future of the global rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets. The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Rosacea Treatment by Segment

The study includes a forecast for the global rosacea treatment by drug class, mode of administration and region.

Rosacea Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Antibiotics
• Alpha agonists
• Retinoids
• Corticosteroids
• Immunosuppressants
• Antihypertensive Agents
• Others

Rosacea Treatment Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Oral

Rosacea Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rosacea Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rosacea treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rosacea treatment companies profiled in this report include-

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• Anaptysbio

Galderma, Allergan, Bayer, Bausch Health Companies, Leo Pharma, Sol-Gel Technologies, Foamix Pharmaceuticals, Aclaris Therapeutics, and AnaptysBio are the major suppliers in the rosacea treatment market.

Rosacea Treatment Market Insights

Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Features of the Global Rosacea Treatment Market

Market Size Estimates: Rosacea treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rosacea treatment market size by drug class, mode of administration, and region in terms of value ($B).

Regional Analysis: Rosacea treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug class, mode of administration, and regions for the rosacea treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rosacea treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rosacea treatment market size?

Answer: The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030.

Q.2 What is the growth forecast for rosacea treatment market?

Answer: The global rosacea treatment market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rosacea treatment market?

Answer: The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

Q4. What are the major segments for rosacea treatment market?

Answer: The future of the rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets.

Q5. Who are the key Rosacea Treatment Market companies?

Answer: Some of the key rosacea treatment companies are as follows.

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• Anaptysbio

Q6. Which rosacea treatment market segment will be the largest in future?

Answer: Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

Q7. In rosacea treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rosacea treatment market by drug class (antibiotics, alpha agonists, retinoids,corticosteroids, immunosuppressants, antihypertensive agents, and others), mode of administration (topical and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rosacea Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rosacea Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rosacea Treatment Market by Drug Class
  • 3.3.1: Antibiotics
  • 3.3.2: Alpha agonists
  • 3.3.3: Retinoids
  • 3.3.4: Corticosteroids
  • 3.3.5: Immunosuppressants
  • 3.3.6: Antihypertensive Agents
  • 3.3.7: Others
• 3.4: Global Rosacea Treatment Market by Mode of Administration
  • 3.4.1: Topical
  • 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rosacea Treatment Market by Region
• 4.2: North American Rosacea Treatment Market
  • 4.2.2: North American Rosacea Treatment Market by Mode of Administration: Topical and Oral
• 4.3: European Rosacea Treatment Market
  • 4.3.1: European Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
  • 4.3.2: European Rosacea Treatment Market by Mode of Administration: Topical and Oral
• 4.4: APAC Rosacea Treatment Market
  • 4.4.1: APAC Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
  • 4.4.2: APAC Rosacea Treatment Market by Mode of Administration: Topical and Oral
• 4.5: ROW Rosacea Treatment Market
  • 4.5.1: ROW Rosacea Treatment Market by Drug Class: Antibiotics, Alpha agonists, Retinoids,Corticosteroids,Immunosuppressants,Antihypertensive Agents, and Others
  • 4.5.2: ROW Rosacea Treatment Market by Mode of Administration: Topical and Oral

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rosacea Treatment Market by Drug Class
  • 6.1.2: Growth Opportunities for the Global Rosacea Treatment Market by Mode of Administration
  • 6.1.3: Growth Opportunities for the Global Rosacea Treatment Market by Region
• 6.2: Emerging Trends in the Global Rosacea Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rosacea Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rosacea Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Galderma
• 7.2: Allergan
• 7.3: Bayer
• 7.4: Bausch Health Companie
• 7.5: Leo Pharma
• 7.6: Sol-Gel Technologies
• 7.7: Foamix Pharmaceuticals
• 7.8: Aclaris Therapeutics
• 7.9: AnaptysBio